These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 6759942)
21. Differences in virulence of Sporothrix schenckii conidia related to culture conditions and cell-wall components. Fernandes KSS; Mathews HL; Bezerra LML J Med Microbiol; 1999 Feb; 48(2):195-203. PubMed ID: 9989648 [TBL] [Abstract][Full Text] [Related]
22. Mast cell activation by conidia of Sporothrix schenckii: role in the severity of infection. Romo-Lozano Y; Hernández-Hernández F; Salinas E Scand J Immunol; 2012 Jul; 76(1):11-20. PubMed ID: 22486186 [TBL] [Abstract][Full Text] [Related]
23. Sporotrichosis--report of a case in Hong Kong. Yip SY; Huang CT Southeast Asian J Trop Med Public Health; 1972 Sep; 3(3):332-9. PubMed ID: 4652463 [No Abstract] [Full Text] [Related]
24. Sporothrix schenckii lipid inhibits macrophage phagocytosis: involvement of nitric oxide and tumour necrosis factor-alpha. Carlos IZ; Sgarbi DB; Santos GC; Placeres MC Scand J Immunol; 2003 Mar; 57(3):214-20. PubMed ID: 12641649 [TBL] [Abstract][Full Text] [Related]
25. Development of experimental sporotrichosis in normal and modified animals. Hachisuka H; Sasai Y Mycopathologia; 1981 Nov; 76(2):79-82. PubMed ID: 6976513 [TBL] [Abstract][Full Text] [Related]
26. Antigenic structures of Sporothrix schenckii. Travassos LR Immunol Ser; 1989; 47():193-221. PubMed ID: 2484980 [No Abstract] [Full Text] [Related]
27. Cell wall proteins of Sporothrix schenckii as immunoprotective agents. Alba-Fierro CA; Pérez-Torres A; López-Romero E; Cuéllar-Cruz M; Ruiz-Baca E Rev Iberoam Micol; 2014; 31(1):86-9. PubMed ID: 24257472 [TBL] [Abstract][Full Text] [Related]
28. Adenosine deaminase activity in serum and lymphocytes of rats infected with Sporothrix schenckii. Castro VS; Pimentel VC; Da Silva AS; Thomé GR; Wolkmer P; Castro JL; Costa MM; da Silva CB; Oliveira DC; Alves SH; Schetinger MR; Lopes ST; Mazzanti CM Mycopathologia; 2012 Jul; 174(1):31-9. PubMed ID: 22169893 [TBL] [Abstract][Full Text] [Related]
29. Human serum proteins bind to Sporothrix schenckii conidia with differential effects on phagocytosis. Guzman Beltrán S; Sanchez Morales J; González Canto A; Escalona Montaño A; Torres Guerrero H Braz J Microbiol; 2021 Mar; 52(1):33-39. PubMed ID: 32382937 [TBL] [Abstract][Full Text] [Related]
30. Immune Response Induced by an Immunodominant 60 kDa Glycoprotein of the Cell Wall of Sporothrix schenckii in Two Mice Strains with Experimental Sporotrichosis. Alba-Fierro CA; Pérez-Torres A; Toriello C; Pulido-Camarillo E; López-Romero E; Romo-Lozano Y; Gutiérrez-Sánchez G; Ruiz-Baca E J Immunol Res; 2016; 2016():6525831. PubMed ID: 27051673 [TBL] [Abstract][Full Text] [Related]
31. Influence of TLR-2 in the immune response in the infection induced by fungus Sporothrix schenckii. de C Negrini T; Ferreira LS; Arthur RA; Alegranci P; Placeres MC; Spolidorio LC; Carlos IZ Immunol Invest; 2014; 43(4):370-90. PubMed ID: 24484374 [TBL] [Abstract][Full Text] [Related]
32. Passive immunization with monoclonal antibody against a 70-kDa putative adhesin of Sporothrix schenckii induces protection in murine sporotrichosis. Nascimento RC; Espíndola NM; Castro RA; Teixeira PA; Loureiro y Penha CV; Lopes-Bezerra LM; Almeida SR Eur J Immunol; 2008 Nov; 38(11):3080-9. PubMed ID: 18991286 [TBL] [Abstract][Full Text] [Related]
33. Anti-inflammatory activity of Vismia guianensis (Aubl.) Pers. extracts and antifungal activity against Sporothrix schenckii. Oliveira AH; de Oliveira GG; Carnevale Neto F; Portuondo DF; Batista-Duharte A; Carlos IZ J Ethnopharmacol; 2017 Jan; 195():266-274. PubMed ID: 27856302 [TBL] [Abstract][Full Text] [Related]
34. An immunoproteomic approach revealing peptides from Sporothrix brasiliensis that induce a cellular immune response in subcutaneous sporotrichosis. de Almeida JRF; Jannuzzi GP; Kaihami GH; Breda LCD; Ferreira KS; de Almeida SR Sci Rep; 2018 Mar; 8(1):4192. PubMed ID: 29520092 [TBL] [Abstract][Full Text] [Related]
35. Optimal clearance of Sporothrix schenckii requires an intact Th17 response in a mouse model of systemic infection. Ferreira LS; Gonçalves AC; Portuondo DL; Maia DC; Placeres MC; Batista-Duharte A; Carlos IZ Immunobiology; 2015 Aug; 220(8):985-92. PubMed ID: 25776919 [TBL] [Abstract][Full Text] [Related]
37. Susceptibility of congenitally athymic (nude) mice to sporotrichosis. Dickerson CL; Taylor RL; Drutz DJ Infect Immun; 1983 Apr; 40(1):417-20. PubMed ID: 6601062 [TBL] [Abstract][Full Text] [Related]
38. Detection of cellular immunity with the soluble antigen of the fungus Sporothrix schenckii in the systemic form of the disease. Carlos IZ; Sgarbi DB; Angluster J; Alviano CS; Silva CL Mycopathologia; 1992 Mar; 117(3):139-44. PubMed ID: 1640975 [TBL] [Abstract][Full Text] [Related]
39. A new variant of Sporothrix schenckii. Ajello L; Kaplan W Mykosen; 1969 Nov; 12(11):633-44. PubMed ID: 4920813 [No Abstract] [Full Text] [Related]
40. A case of disseminating sporotrichosis from South Africa. Brandt FA; van Niekerk V Sabouraudia; 1969 Feb; 7(1):46-50. PubMed ID: 5375341 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]